about
The effects of hyperoxic and hypercarbic gases on tumour blood flow.The effects of host carbogen (95% oxygen/5% carbon dioxide) breathing on metabolic characteristics of Morris hepatoma 9618aApplications of magnetic resonance in model systems: tumor biology and physiology.Hypoxia imaging using PET and SPECT: the effects of anesthetic and carrier gas on [Cu]-ATSM, [Tc]-HL91 and [F]-FMISO tumor hypoxia accumulation.Enhanced uptake of ifosfamide into GH3 prolactinomas with hypercapnic hyperoxic gases monitored in vivo by (31)P MRS.The 1991 Elis Berven Lecture. Radiotherapy in the nineties. Increase in cure, decrease in morbidity.Current issues in the utility of 19F nuclear magnetic resonance methodologies for the assessment of tumour hypoxia.Modulation of the tumor vasculature and oxygenation to improve therapyFurther evaluation of nicotinamide and carbogen as a strategy to reoxygenate hypoxic cells in vivo: importance of nicotinamide dose and pre-irradiation breathing time.The influence of carbogen breathing on tumour tissue oxygenation in man evaluated by computerised p02 histography.The effects of carbogen and nicotinamide on intravascular oxyhaemoglobin saturations in SCCVII and KHT murine tumours.Perfusion changes in the RIF-1 tumour and normal tissues after carbogen and nicotinamide, individually and combined.The mechanisms by which hyperbaric oxygen and carbogen improve tumour oxygenation.Carbogen breathing with nicotinamide improves the oxygen status of tumours in patientsCarbogen and nicotinamide in the treatment of bladder cancer with radical radiotherapy.Nicotinamide and other benzamide analogs as agents for overcoming hypoxic cell radiation resistance in tumours. A review.Comparison of the effectiveness of tirapazamine and carbogen with nicotinamide in enhancing the response of a human tumor xenograft to fractionated irradiation.Response of hepatoma 9618a and normal liver to host carbogen and carbon monoxide breathingGas exchange parameters in radiotherapy patients during breathing of 2%, 3.5% and 5% carbogen gas mixtures.Issues of normal tissue toxicity in patient and animal studies--effect of carbogen breathing in rats after 5-fluorouracil treatment.Is sensitization with nicotinamide and carbogen dependent on nicotinamide concentration at the time of irradiation?Carbogen breathing in patients with glioblastoma multiforme submitted to radiotherapy. Assessment of gas exchange parameters.Pharmacokinetics and tolerance of nicotinamide combined with radiation therapy in patients with glioblastoma multiforme.Modified oxygen mask to induce target levels of hyperoxia and hypercarbia during radiotherapy: a more effective alternative to carbogen.
P2860
Q30632172-F2717703-1D93-48EE-89F5-7C8E8860F294Q31962982-F6F351CD-BAAE-4AD6-827B-81526C5B234BQ33995805-93EE9C9C-4D42-4E7D-B020-46F150505871Q34079208-4A3D27B6-67EF-4E19-93AC-CFF54049C391Q34775825-31CD0580-94BD-4F45-9FE7-6879B38FA903Q35455623-3EC5A303-B8E1-4B97-AC9E-6EDC84103947Q35861042-1F62D755-273D-4DEC-8955-EB2C0B3BF4B3Q35920685-B6497F6F-E24D-4F57-9420-DB3D9F81FF6DQ35977171-8CD41B69-238F-4C7A-B81D-495108561E63Q35994518-AD9EB1A7-9697-4848-8A02-AE32EF8829BAQ36080887-C44762FA-B17C-4367-93DB-4FB45261CCE1Q36081011-FDFC889C-D678-414E-823B-E83642A05A92Q36081421-894BF4E6-40E2-4E1F-A85F-DD0E5748F393Q36081866-CADA60C6-D7F0-4846-B89A-C6F905CA051FQ36422762-82C86AA7-0849-4925-A4F6-A0D57A8BC534Q40405347-8AEECEA8-45C6-4774-8C53-5F5BF14EEEB3Q40941945-7492885E-0EBA-409D-BFEA-FD9CD3575F73Q42360010-F91C4823-94AC-4C4A-97A6-F80FB93513BBQ42501715-0E2C2940-C511-4213-8607-A74A74FA6B9BQ43773750-8F975D93-DB7D-4B2C-AD2F-06A14BE81C1EQ45053724-A85052E7-2BEA-43A0-A2F8-3E166086C79BQ48217801-EDF36396-0D39-40B2-AB10-084798C3ECFCQ50750502-C7A4CE97-D757-4057-A970-96C59CE31A98Q50991675-E6302565-8534-48DA-8A0F-CE6DB66A1FCE
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 1991
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Radiosensitization with normobaric oxygen and carbogen.
@en
Radiosensitization with normobaric oxygen and carbogen.
@nl
type
label
Radiosensitization with normobaric oxygen and carbogen.
@en
Radiosensitization with normobaric oxygen and carbogen.
@nl
prefLabel
Radiosensitization with normobaric oxygen and carbogen.
@en
Radiosensitization with normobaric oxygen and carbogen.
@nl
P1476
Radiosensitization with normobaric oxygen and carbogen.
@en
P2093
P356
10.1016/0167-8140(91)90190-R
P478
20 Suppl 1
P577
1991-01-01T00:00:00Z